Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Bundamedik TbkISX:BMHS 61 EV-to-FCF is 90.34 as of Jul. 17, 2026. GuruFocus rates ISX:BMHS with a GF Score™ of 61/100 and a GF Value™ of Rp307.97 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 406 Healthcare Providers & Services companies, PT Bundamedik Tbk ranks worse than 89.9% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PT Bundamedik Tbk's Enterprise Value is Rp3,081,481 Mil.
PT Bundamedik Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was Rp34,112 Mil. Therefore, PT Bundamedik Tbk's EV-to-FCF for today is 90.34.
The historical rank and industry rank for PT Bundamedik Tbk's EV-to-FCF or its related term are showing as below:
ISX:BMHS'
s EV-to-FCF Range Over the Past 10 Years
Min: -176.24 Med: -18.05 Max: 169.38
Current: 90.08
During the past 8 years, the highest EV-to-FCF of PT Bundamedik Tbk was 169.38. The lowest was -176.24. And the median was -18.05.
ISX:BMHS's EV-to-FCF is ranked worse than 89.9% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.99
vs ISX:BMHS: 90.08
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Bundamedik Tbk's PE Ratio (TTM) for today is calculated as:
PT Bundamedik Tbk's share price for today is Rp176.00.
PT Bundamedik Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0.983.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PT Bundamedik Tbk EV-to-FCF Related Terms
PT Bundamedik Tbk EV-to-FCF Historical Data
* Premium members only.
The historical data trend for PT Bundamedik Tbk's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PT Bundamedik Tbk's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Bundamedik Tbk EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PT Bundamedik Tbk's EV-to-FCF falls into.
PT Bundamedik Tbk's current Enterprise Value is Rp3,081,481 Mil.
PT Bundamedik Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp34,112 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Bundamedik Tbk (ISX:BMHS) has a EV-to-FCF of 90.34 as of Jul. 17, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Bundamedik Tbk and its competitors. According to the industry distribution chart, PT Bundamedik Tbk ranks #365 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 89.9%.
Is PT Bundamedik Tbk's EV-to-FCF too high?
PT Bundamedik Tbk's current EV-to-FCF is 90.34. The Healthcare Providers & Services industry median EV-to-FCF is 17.99. PT Bundamedik Tbk's value of 90.34 is 402.2% above this industry median. Based on the distribution chart, PT Bundamedik Tbk ranks #365 out of 406 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Bundamedik Tbk has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Bundamedik Tbk ranks #365 out of 406 companies for EV-to-FCF. This places PT Bundamedik Tbk in the lower half of its industry. The industry median EV-to-FCF is 17.99. PT Bundamedik Tbk's value of 90.34 is 402.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.99, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Bundamedik Tbk's current EV-to-FCF of 90.34 is 402.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on PT Bundamedik Tbk and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Bundamedik Tbk's current EV-to-FCF is 90.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Possible Value Trap. The stock's GF Value™ is Rp307.97, compared to a current price of Rp176.00 — trading 42.9% below its estimated fair value. The current EV-to-FCF is 90.34 and 402.2% above the Healthcare Providers & Services industry median of 17.99. PT Bundamedik Tbk's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current EV-to-FCF is 90.34 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued.
The current stock price of Rp176.00 is trading 42.9% below its estimated GF Value™ of Rp307.97.
GuruFocus considers PT Bundamedik Tbk to be Possible Value Trap.
Key valuation signals for ISX:BMHS:
EV-to-FCF: 90.34
GF Value™: Rp307.97 vs. price of Rp176.00 (42.9% below fair value)
Industry Position: 402.2% above the Healthcare Providers & Services median (#365 of 406)
No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
61GF Score
Get the complete analysis for ISX:BMHS
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:BMHS has been successfully added to your 
